MARRONE BIO INNOVATIONS INC. Lease, Cost
MARRONE BIO INNOVATIONS INC. reported Lease, Cost of $401.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-05-13
- MARRONE BIO INNOVATIONS INC. lease, cost for the quarter ending 2022-03-31 was $401.00K, a 21.15% increase year-over-year.
- MARRONE BIO INNOVATIONS INC. lease, cost for the quarter ending 2021-12-31 was $339.00K, a 3.69% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. lease, cost for the quarter ending 2021-09-30 was $403.00K, a 25.55% increase year-over-year.
- MARRONE BIO INNOVATIONS INC. lease, cost for the quarter ending 2021-06-30 was $376.00K, a 20.90% increase year-over-year.
- MARRONE BIO INNOVATIONS INC. lease, cost for fiscal 2021 was $1.45M, a 11.63% increase from fiscal 2020.
- MARRONE BIO INNOVATIONS INC. lease, cost for fiscal 2020 was $1.30M, a 12.97% increase from fiscal 2019.
- MARRONE BIO INNOVATIONS INC. lease, cost for fiscal 2019 was $1.15M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-03-31 | $401.00K 10-Q · filed 2022-05-13 | $740.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.14M derived: sum of 3 quarters · filed 2022-05-13 | $1.52M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $339.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $742.00K derived: sum of 2 quarters · filed 2022-05-09 | $1.12M derived: sum of 3 quarters · filed 2022-05-09 | $1.45M 10-K/A · filed 2022-05-09 |
| 2021-09-30 | $403.00K 10-Q · filed 2021-11-10 | $779.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.11M 10-Q · filed 2021-11-10 | $1.46M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $376.00K 10-Q · filed 2021-08-16 | $707.00K 10-Q · filed 2021-08-16 | $1.06M derived: sum of 3 quarters · filed 2022-05-13 | $1.38M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $331.00K 10-Q · filed 2022-05-13 | $683.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.00M derived: sum of 3 quarters · filed 2022-05-13 | $1.31M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $352.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $673.00K derived: sum of 2 quarters · filed 2022-05-09 | $984.00K derived: sum of 3 quarters · filed 2022-05-09 | $1.30M 10-K/A · filed 2022-05-09 |
| 2020-09-30 | $321.00K 10-Q · filed 2021-11-10 | $632.00K derived: sum of 2 quarters · filed 2021-11-10 | $946.00K 10-Q · filed 2021-11-10 | $1.24M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $311.00K 10-Q · filed 2021-08-16 | $625.00K 10-Q · filed 2021-08-16 | $920.00K derived: sum of 3 quarters · filed 2021-08-16 | $1.20M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $314.00K 10-Q · filed 2021-05-13 | $609.00K derived: sum of 2 quarters · filed 2021-05-13 | $891.00K derived: sum of 3 quarters · filed 2021-05-13 | $1.18M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $577.00K derived: sum of 2 quarters · filed 2021-03-23 | $862.00K derived: sum of 3 quarters · filed 2021-03-23 | $1.15M 10-K · filed 2021-03-23 |
| 2019-09-30 | $282.00K 10-Q · filed 2020-11-09 | $567.00K derived: sum of 2 quarters · filed 2020-11-09 | $854.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $285.00K 10-Q · filed 2020-08-10 | $572.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $287.00K 10-Q · filed 2020-05-11 |